Can-Fite BioPharma Ltd.
CANF · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$7,880 | -$7,634 | -$10,173 | -$12,615 |
| Dep. & Amort. | $7 | $15 | $14 | $14 |
| Deferred Tax | $0 | $0 | $0 | -$94 |
| Stock-Based Comp. | $362 | $261 | $263 | $466 |
| Change in WC | -$267 | -$943 | -$1,301 | $2,430 |
| Other Non-Cash | $141 | -$139 | $396 | -$59 |
| Operating Cash Flow | -$7,637 | -$8,440 | -$10,801 | -$9,858 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$5 | -$2 | -$9 | -$11 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | -$14,500 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $1,500 | $500 | $9,511 | $0 |
| Investing Cash Flow | $1,495 | $498 | $9,502 | -$14,511 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $6,711 | $9,144 | $0 | $20,457 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $6,711 | $9,144 | $0 | $20,457 |
| Forex Effect | -$22 | $98 | -$113 | $34 |
| Net Chg. in Cash | $547 | $1,300 | -$1,412 | -$3,878 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $4,278 | $2,978 | $4,390 | $8,268 |
| End Cash | $4,825 | $4,278 | $2,978 | $4,390 |
| Free Cash Flow | -$7,642 | -$8,442 | -$10,810 | -$9,869 |